Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments
Details for Australian Patent Application No. 2002331361 (hide)
International Classifications
Event Publications
6 February 2003 Complete Application Filed
Priority application(s): 01118593.1 02.08.01 EP; 01130180.1 19.12.01 EP
19 June 2003 Application Open to Public Inspection
Published as AU-B-2002331361
14 December 2006 Amendment Made
The nature of the amendment is: Add co-inventor Schneider, Heinrich
5 June 2008 Application Accepted
Published as AU-B-2002331361
2 October 2008 Standard Patent Sealed
30 August 2012 Assignment Registered
Bidachem S.P.A. The patent has been assigned to Sprout Pharmaceuticals, Inc.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002331362-NEW ALKYNYLATED QUINAZOLIN COMPOUNDS AS MMP-13 INHIBITORS
2002331360-Use of LHRH-antagonists for the improvement of T-cell mediated immunity
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser